[Atorvastatin in correction of metabolic syndrome: clinico-economical assessment of efficacy].
Khokhlov
A L
AL
Zhilina
A N
AN
Buĭdina
T A
TA
D000069059:Atorvastatin; D003365:Costs and Cost Analysis; D005260:Female; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000188:drug therapy* / Q000191:economics; D008875:Middle Aged; D011758:Pyrroles / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D000069059:Atorvastatin